© Reuters. FILE PHOTO: FILE PHOTO: An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. REUTERS/Mike Segar/File Photo
(Reuters) – Eli Lilly (NYSE:) and Co said on Tuesday it expects adjusted profit in the range of $8.10 to $8.30 per share in 2023.
The adjusted profit forecast was lower than analysts’ average estimate of $9.15 per share, according to Refinitiv IBES data.
Be the first to comment